Sign in
CompletedPhase 2

Testosterone and Long Pulse Stimulation After SCI

Key facts

Who runs it
VA Office of Research and Development
Where
Richmond, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
12 people enrolled
Started
1 Jul 2018
Ended
30 Nov 2023
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Testosterone and LPWS
  • Testosterone and standard NMES
Record updated
14 October 2025

Who can take part

Age
18 years to 70 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Traumatic motor complete SCI and level of injury of T10 and below
  • Only participants with lower motor neuron (LMN) denervation as determined by EMG testing
  • Participants must also have an absence of reflexes, denervation of both knee extensor muscles
  • Tolerance to LPWS paradigm
  • Both knee extensors will also have to be unresponsive (i.e., no observed tetanic contraction or twitches) to standard electrical stimulation procedures (stimulation frequency: 30 Hz; pulse duration:450 s and amplitude of the current:200 mA)
  • All participants will undergo International Standards for Neurological Classification of SCI (ISNCSCI) examination for neurological level and function and only those with American Spinal Injury Classification (AIS A and B; i.e. motor deficit below the level of injury)

Who cannot take part

  • Pre-existing medical conditions will be excluded (cardiovascular disease, uncontrolled type II DM and those on insulin requirements) or other concurrent medical conditions judged to be contraindicated by the site physician
  • Hematocrit above 50% and severe urinary tract infection or symptoms
  • Progressive condition that would be expected to result in changing neurological status
  • Untreated or uncontrolled hypertension (systolic blood pressure >140 mmHg; diastolic blood pressure >90 mmHg)
  • Pressure ulcer of the trunk, pelvic area, or lower extremities of grade 3 or more
  • Diagnosis of neurological injury other than SCI
  • Those with hyper-physiological testosterone level above 800 ng/dl
  • Those who will fail to tolerate the LPWS paradigm
  • Lower extremity fracture around the knee joint (distal femur or proximal tibia) within the last 2 years from enrollment in the study
  • Knee BMD < 0.60 gm/cm2
  • Total hip BMD T-scores < -3.5
  • Untreatable severe spasticity judged to be contraindicated by the site Physician
  • Psychopathology documentation in the medical record or history that may conflict with study objectives

Where in United States

  • Hunter Holmes McGuire VA Medical Center, Richmond, VARichmond, United States

About the trial

What the trial wants to find out

Denervation following spinal cord injury (SCI) limits beneficial application of neuromuscular electrical stimulation (NMES). SCI with denervation results in extensive muscle atrophy that is accompanied with several cardio-metabolic health risks. The current proposal provides a novel intervention by examining the effects of long pulse width stimulation (LPWS) and testosterone replacement therapy (TRT) on restoring muscle size and leg lean mass after denervation in persons with SCI. This intervention will be rewarding for Veterans and Civilians with SCI who do not benefit from exercising their lower extremity muscles because denervation has limited the response to standard surface NMES. The investigators will study the biochemical mechanisms that contribute to changes in muscle size following this novel training. Combing both pharmaceutical and physical-therapeutic interventions will optimize restoration of muscle size after SCI.

The 2 groups in the trial

  • Testosterone and LPWSTreatment being tested

    Twelve patients will undergo 1 year of supervised training examining the effects of testosterone replacement therapy (TRT) and long pulse width stimulation (LPWS) in persons with denervated spinal cord injury.

  • Testosterone and standard NMESSham treatment, for comparison

    Twelve patients will undergo 1 year of supervised training examining the effects of testosterone replacement therapy (TRT) and standard surface neuromuscular electrical stimulation (NMES) in persons with denervated spinal cord injury.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Testosterone and Long Pulse Width Stimulation for Denervated Muscles After Spinal Cord Injury
Publications
Record updated
14 October 2025